Since NK cells are potent producers of IFN-γ that were identified in HS lesions (Supplemental Figure 2E), these data suggest that NK cells are primed for effector functions in patients with HS and that their local activation may contribute to IDO1 induction in lesional skin. This evidence concerns the gene IFNG and histiocytic sarcoma.